Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential of regulatory T cell-based therapies for alopecia areata. | Front Immunol | 2023 | 37205097 | PubTator, text mining | PubMed |
| Stimulatory effects of Lycium shawii on human melanocyte proliferation, migration, and melanogenesis: In vitro and in silico studies. | Front Pharmacol | 2023 | 37197407 | PubTator, text mining | PubMed |
| A census of actin-associated proteins in humans. | Front Cell Dev Biol | 2023 | 37187613 | PubTator, text mining | PubMed |
| Identifying Genomic Signatures of Positive Selection to Predict Protective Genomic Loci in the Cohort of Lithuanian Clean-Up Workers of the Chornobyl Nuclear Disaster. | Curr Issues Mol Biol | 2023 | 37185719 | PubTator, text mining | PubMed |
| Recent Advances in Characterization of Melanin Pigments in Biological Samples. | Int J Mol Sci | 2023 | 37176019 | PubTator, text mining | PubMed |
| Naturally-Occurring Tyrosinase Inhibitors Classified by Enzyme Kinetics and Copper Chelation. | Int J Mol Sci | 2023 | 37175965 | PubTator, text mining | PubMed |
| Efficient Isolation and Expansion of Limbal Melanocytes for Tissue Engineering. | Int J Mol Sci | 2023 | 37175529 | PubTator, text mining | PubMed |
| Circulating Tumour DNA (ctDNA) as a Predictor of Clinical Outcome in Non-Small Cell Lung Cancer Undergoing Targeted Therapies: A Systematic Review and Meta-Analysis. | Cancers (Basel) | 2023 | 37173891 | PubTator, text mining | PubMed |
| Revealing the roles of glycosphingolipid metabolism pathway in the development of keloid: a conjoint analysis of single-cell and machine learning. | Front Immunol | 2023 | 37168863 | PubTator, text mining | PubMed |
| A Cross-Sectional Study of the Levels of Cytokines IL-6, TNF-α, and IFN-γ in Blood and Skin (Lesional and Uninvolved) of Vitiligo Patients and their Possible Role as Biomarkers. | Indian J Dermatol | 2023 | 37151272 | PubTator, text mining | PubMed |
| Altered zinc homeostasis in a primary cell culture model of the retinal pigment epithelium. | Front Nutr | 2023 | 37139441 | PubTator, text mining | PubMed |
| Nodakenin Inhibits Melanogenesis Via the ERK/MSK1 Signaling Pathway. | Pharmazie | 2023 | 37138409 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of the ocular anterior segment: a comprehensive review. | Eye (Lond) | 2023 | 37138096 | PubTator, text mining | PubMed |
| Tetrahedral framework nucleic acid loaded with glabridin: A transdermal delivery system applicated to anti-hyperpigmentation. | Cell Prolif | 2023 | 37132449 | PubTator, text mining | PubMed |
| Copper-binding proteins genes set predicting the overall survival and immune infiltration in hepatocellular carcinoma by bioinformatic analysis. | Biochem Biophys Rep | 2023 | 37125079 | PubTator, text mining | PubMed |
| Silk Fibroin-Based Hydrogel Microneedles Deliver α-MSH to Promote Melanosome Delivery for Vitiligo Treatment. | ACS Biomater Sci Eng | 2023 | 37115665 | PubTator, text mining | PubMed |
| Design, Synthesis, In Vitro, and In Silico Insights of 5-(Substituted benzylidene)-2-phenylthiazol-4(5H)-one Derivatives: A Novel Class of Anti-Melanogenic Compounds. | Molecules | 2023 | 37110531 | PubTator, text mining | PubMed |
| Characterization of Porcine Ocular Surface Epithelial Microenvironment. | Int J Mol Sci | 2023 | 37108705 | PubTator, text mining | PubMed |
| Hydrolyzed Conchiolin Protein (HCP) Extracted from Pearls Antagonizes both ET-1 and α-MSH for Skin Whitening. | Int J Mol Sci | 2023 | 37108635 | PubTator, text mining | PubMed |
| Fake drugs: Using Baseline Spectral Fingerprinting and a sorting algorithm to infer quality of medications. | PLoS One | 2023 | 37099593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=16